Product Code: ETC332189 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Philippines market for measles, mumps, and rubella (MMR) vaccines has grown steadily, with a CAGR of about 2.8%. Vaccination campaigns and government initiatives to enhance immunization coverage have been instrumental in maintaining a healthier population.
The Philippines measles, mumps, and rubella (MMR) vaccines market is driven by the importance of immunization in preventing contagious diseases. MMR vaccines are crucial for maintaining public health by preventing outbreaks of these viral infections. The government`s efforts to promote vaccination programs and the awareness among parents about the significance of childhood immunization contribute to the growth of the MMR vaccines market.
The Philippines faces significant challenges in its Measles, Mumps, and Rubella (MMR) vaccines market. Despite efforts to promote vaccination campaigns, there remain issues of vaccine hesitancy, misinformation, and inadequate healthcare infrastructure in some regions. Overcoming these challenges is crucial to achieving high vaccination coverage and preventing outbreaks of these preventable diseases.
The focus on COVID-19 vaccinations and the disruption of healthcare services during the pandemic have impacted routine immunization programs, including those for measles, mumps, and rubella. The market has faced challenges in terms of reduced vaccination rates.
Key players in the Philippines Measles Mumps And Rubella Vaccines Market include GlaxoSmithKline plc, Merck & Co., Inc., and Sanofi S.A.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Measles, Mumps And Rubella Vaccines Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Measles, Mumps And Rubella Vaccines Market - Industry Life Cycle |
3.4 Philippines Measles, Mumps And Rubella Vaccines Market - Porter's Five Forces |
3.5 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Philippines Measles, Mumps And Rubella Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Government initiatives promoting vaccination programs |
4.2.2 Increasing awareness about the importance of measles, mumps, and rubella vaccines |
4.2.3 Rising incidences of outbreaks and diseases related to measles, mumps, and rubella |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 Vaccine hesitancy and misinformation |
4.3.3 High cost of vaccines |
5 Philippines Measles, Mumps And Rubella Vaccines Market Trends |
6 Philippines Measles, Mumps And Rubella Vaccines Market, By Types |
6.1 Philippines Measles, Mumps And Rubella Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Monovalent, 2021-2031F |
6.1.4 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Combinational, 2021-2031F |
6.1.5 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Divalent, 2021-2031F |
6.1.6 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Trivalent, 2021-2031F |
6.1.7 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021-2031F |
6.2 Philippines Measles, Mumps And Rubella Vaccines Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Healthcare Centers, 2021-2031F |
6.2.4 Philippines Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Measles, Mumps And Rubella Vaccines Market Import-Export Trade Statistics |
7.1 Philippines Measles, Mumps And Rubella Vaccines Market Export to Major Countries |
7.2 Philippines Measles, Mumps And Rubella Vaccines Market Imports from Major Countries |
8 Philippines Measles, Mumps And Rubella Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates for measles, mumps, and rubella vaccines |
8.2 Number of reported cases of measles, mumps, and rubella |
8.3 Percentage of population vaccinated with recommended doses |
8.4 Adverse events following immunization (AEFI) rates |
8.5 Healthcare infrastructure development in remote areas |
9 Philippines Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment |
9.1 Philippines Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Philippines Measles, Mumps And Rubella Vaccines Market - Competitive Landscape |
10.1 Philippines Measles, Mumps And Rubella Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Philippines Measles, Mumps And Rubella Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |